Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CCL22 |
| Upstream (Parents) |
|---|
| (<<) C5AR1 → CCL22 |
| (<<) BHLHE41 → CCL22 |
| (<<) TFEC → CCL22 |
| (<<) MNDA → CCL22 |
| (<<) CLEC7A → CCL22 |
| Downstream (Children) |
|---|
| CCL22 → ZNF81 (>>) |
| CCL22 → ADRA1D (>>) |
| CCL22 → RGS13 (>>) |
| CCL22 → TTTY2 (>>) |
| CCL22 → DLK1 (>>) |
| CCL22 → PNOC (>>) |
| CCL22 → EYA4 (>>) |
| CCL22 → GGH (>>) |
| CCL22 → UCP1 (>>) |
| CCL22 → RAB33A (>>) |
